? Core D (Administrative Core) The Administrative Core (Core D) will be responsible for the overall administration of the P01 program. It will provide clerical support, meeting organization, data management and planning/evaluation services to this Program. The responsibilities of Core D include the following aims: (1) Monitoring research progress in the P01 program via monthly scientific meetings and quarterly progress updates; (2) Providing scientific oversight and research direction both from the Core D leader, Dr. DePinho, and also from the experienced membership of this program's Scientific Advisory Board; (3) Fostering communication and collaboration between P01 program participants by facilitating meetings (in person and via the internet), managing a annual program retreat, and maintaining a website for program data sharing and communication; (4) Providing fiscal oversight and resource allocation including the review accounting summaries to ensure fiscal management, enabling subcontracts, and establishing cost centers and reporting practices; and (5) Facilitating data and reagent sharing and dissemination.

Public Health Relevance

? Core D (Administrative Core) The Administrative Core (Core D) will be responsible for the overall administration of this P01 program. It will provide clerical support, meeting organization, data management and planning/evaluation services to enable effective research into PDAC biology and genetics for the purpose of informing on clinical treatment and outcomes.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Research Program Projects (P01)
Project #
5P01CA117969-14
Application #
9694187
Study Section
Special Emphasis Panel (ZCA1)
Project Start
Project End
Budget Start
2019-04-01
Budget End
2020-03-31
Support Year
14
Fiscal Year
2019
Total Cost
Indirect Cost
Name
University of Texas MD Anderson Cancer Center
Department
Type
DUNS #
800772139
City
Houston
State
TX
Country
United States
Zip Code
77030
Lundquist, Mark R; Goncalves, Marcus D; Loughran, Ryan M et al. (2018) Phosphatidylinositol-5-Phosphate 4-Kinases Regulate Cellular Lipid Metabolism By Facilitating Autophagy. Mol Cell 70:531-544.e9
Hopkins, Benjamin D; Pauli, Chantal; Du, Xing et al. (2018) Suppression of insulin feedback enhances the efficacy of PI3K inhibitors. Nature 560:499-503
Biancur, Douglas E; Kimmelman, Alec C (2018) The plasticity of pancreatic cancer metabolism in tumor progression and therapeutic resistance. Biochim Biophys Acta Rev Cancer 1870:67-75
Chen, Yang; LeBleu, Valerie S; Carstens, Julienne L et al. (2018) Dual reporter genetic mouse models of pancreatic cancer identify an epithelial-to-mesenchymal transition-independent metastasis program. EMBO Mol Med 10:
Hill, Margaret A; Alexander, William B; Guo, Bing et al. (2018) Kras and Tp53 Mutations Cause Cholangiocyte- and Hepatocyte-Derived Cholangiocarcinoma. Cancer Res 78:4445-4451
Mendt, Mayela; Kamerkar, Sushrut; Sugimoto, Hikaru et al. (2018) Generation and testing of clinical-grade exosomes for pancreatic cancer. JCI Insight 3:
Patra, Krushna C; Kato, Yasutaka; Mizukami, Yusuke et al. (2018) Mutant GNAS drives pancreatic tumourigenesis by inducing PKA-mediated SIK suppression and reprogramming lipid metabolism. Nat Cell Biol 20:811-822
Anglin, Justin; Zavareh, Reza Beheshti; Sander, Philipp N et al. (2018) Discovery and optimization of aspartate aminotransferase 1 inhibitors to target redox balance in pancreatic ductal adenocarcinoma. Bioorg Med Chem Lett 28:2675-2678
Yang, Annan; Herter-Sprie, Grit; Zhang, Haikuo et al. (2018) Autophagy Sustains Pancreatic Cancer Growth through Both Cell-Autonomous and Nonautonomous Mechanisms. Cancer Discov 8:276-287
Santana-Codina, Naiara; Roeth, Anjali A; Zhang, Yi et al. (2018) Oncogenic KRAS supports pancreatic cancer through regulation of nucleotide synthesis. Nat Commun 9:4945

Showing the most recent 10 out of 134 publications